Riitta Lassila: How APAC Impacts the Interplay Between Complement and Coagulation
Riitta Lassila, Professor of Coagulation Medicine at University of Helsinki, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Our team has published about how the heparin proteoglycan mimic APAC impacts the interplay between complement system and coagulation.
The regulatory functions and cellular clearance of debris are supported – an anti-inflammatory effect aligning with the antithrombotic mechanisms of APAC (by Aplagon).”
Title: Interactions of Antiplatelet, Anticoagulant (APAC) with C1q and FH modulate complement activation on injured cells
Authors: Juha Kotimaa, Mikel Artero Rezola, Annukka Jouppila, Riitta Lassila, Seppo Meri
Read the Full Article on Blood Vessels, Thrombosis and Hemostasis.
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 5, 2026, 02:45Marie Luise Hütter-Krönke: Can a Short Course of BCMA-Targeted Therapy Induce Long-Term Remission in Refractory Autoimmune Disease?
-
Jul 5, 2026, 02:24Shreya Agarwa: Transforming Care For Adolescents With Heavy Menstrual Bleeding
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders